Metabolomics Reveals Metabolic Biomarkers of Crohn's Disease

The causes and etiology of Crohn's disease (CD) are currently unknown although both host genetics and environmental factors play a role. Here we used non-targeted metabolic profiling to determine the contribution of metabolites produced by the gut microbiota towards disease status of the host. Ion Cyclotron Resonance Fourier Transform Mass Spectrometry (ICR-FT/MS) was used to discern the masses of thousands of metabolites in fecal samples collected from 17 identical twin pairs, including healthy individuals and those with CD. Pathways with differentiating metabolites included those involved in the metabolism and or synthesis of amino acids, fatty acids, bile acids and arachidonic acid. Several metabolites were positively or negatively correlated to the disease phenotype and to specific microbes previously characterized in the same samples. Our data reveal novel differentiating metabolites for CD that may provide diagnostic biomarkers and/or monitoring tools as well as insight into potential targets for disease therapy and prevention.

• Publication year

  2009

• Venue

  PLoS ONE

• Publication date

  2009-07-28

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1371/journal.pone.0006386PMID 19636438PMCID 2713417
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Twin studies reveal specific imbalances in the mucosa‐associated microbiota of patients with ileal Crohn's disease

  2009influential reference
• Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites

  2009cited by this paper
• Molecular analysis of the gut microbiota of identical twins with Crohn's disease

  2008cited by this paper
• Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients

  2008cited by this paper
• Symbiotic gut microbes modulate human metabolic phenotypes

  2008cited by this paper
• Practical approach for the identification and isomer elucidation of biomarkers detected in a metabonomic study for the discovery of individuals at risk for diabetes by integrating the chromatographic and mass spectrometric information.

  2008cited by this paper
• Protein tyrosine phosphatases in autoimmunity.

  2008cited by this paper
• MassTRIX: mass translator into pathways

  2008cited by this paper
• Metabolic evidence for biogeographic isolation of the extremophilic bacterium Salinibacter ruber

  2008cited by this paper
• Shotgun metaproteomics of the human distal gut microbiota

  2008cited by this paper
• Species variation in the fecal metabolome gives insight into differential gastrointestinal function.

  2008cited by this paper
• Human metabolic phenotype diversity and its association with diet and blood pressure

  2008cited by this paper
• Culture independent analysis of ileal mucosa reveals a selective increase in invasive Escherichia coli of novel phylogeny relative to depletion of Clostridiales in Crohn's disease involving the ileum

  2007cited by this paper
• Rapid and noninvasive metabonomic characterization of inflammatory bowel disease.

  2007cited by this paper
• Arachidonic Acid but not Eicosapentaenoic Acid (EPA) and Oleic Acid Activates NF-κB and Elevates ICAM-1 Expression in Caco-2 Cells

  2007cited by this paper
• Novel Crohn Disease Locus Identified by Genome-Wide Association Maps to a Gene Desert on 5p13.1 and Modulates Expression of PTGER4

  2007cited by this paper
• The Proinflammatory Effect of Prostaglandin E2 in Experimental Inflammatory Bowel Disease Is Mediated through the IL-23→IL-17 Axis1

  2007cited by this paper
• Mechanisms of Disease: pathogenesis of Crohn's disease and ulcerative colitis

  2006cited by this paper
• Molecular classification of Crohn's disease and ulcerative colitis patients using transcriptional profiles in peripheral blood mononuclear cells.

  2006cited by this paper
• Dopamine D2 Receptor Polymorphisms in Inflammatory Bowel Disease and the Refractory Response to Treatment

  2006cited by this paper
• Gallbladder bile composition in patients with Crohn 's disease.

  2006cited by this paper
• Gut microorganisms, mammalian metabolism and personalized health care

  2005cited by this paper
• Human fecal water inhibits COX-2 in colonic HT-29 cells: role of phenolic compounds.

  2005cited by this paper
• Inflammatory bowel disease in a Swedish twin cohort: a long-term follow-up of concordance and clinical characteristics.

  2003cited by this paper
• Inflammatory-mediated repression of the rat ileal sodium-dependent bile acid transporter by c-fos nuclear translocation.

  2002cited by this paper
• Human intestinal cell monolayers are preferentially sensitive to disruption of barrier function from basolateral exposure to cholic acid: correlation with membrane transport and transepithelial secretion

  2001cited by this paper
• Impaired synthesis or cellular storage of norepinephrine, dopamine and 5-hydroxytryptamine in inflammatory bowel disease

  2000cited by this paper
• Changes in mucosal fatty acid profile in inflammatorybowel disease and in experimental colitis: a common response to bowel inflammation.

  1997cited by this paper
• Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum.

  1991cited by this paper
• A simple index of Crohn's-disease activity.

  1980cited by this paper
• Serum tryptophan in Crohn's disease.

  1976cited by this paper
• Serum tryptophan in Crohn's disease.

  1976cited by this paper

• The beneficial effect of a multispecies probiotic intervention on quality of sleep - a randomized, double-blinded, placebo-controlled study.

  2026cites this paper
• Identifying Metabolite-Disease Associations via Messaging in Hypergraphs.

  2026cites this paper
• The role of bile acid dynamics in inflammatory bowel disease and metabolic dysfunction-associated steatotic liver disease

  2026cites this paper
• Advances in multi-omics integrated analysis methods based on the gut microbiome and their applications

  2025cites this paper
• Differentiating Canine Chronic Inflammatory Enteropathies Using Faecal Amino Acid Profiles: Potential and Limitations

  2025cites this paper
• Fecal metabolomics in Crohn's disease reveal N-Acetylglutamine as a Th17/Treg modulator.

  2025cites this paper
• Fecal Arachidonic Acid: A Potential Biomarker for Inflammatory Bowel Disease Severity

  2025cites this paper
• Advances in Gut Microbiome and Metabolomics Research in the Comorbidity of Inflammatory Bowel Disease and Depressive Disorder

  2025cites this paper
• The Microbiome and the Etiology of Diverticulitis.

  2025cites this paper
• The metabolic landscape of connective tissue diseases: Applications and discoveries in metabolomics research.

  2025cites this paper
• Understanding How Mental Health Influences IBD Outcomes: A Review of Potential Culprit Biological Mechanisms

  2025cites this paper
• Markers of Gut Health in Small Animals: Focus on Fatty Acids and Amino Acids as Indicators of Intestinal Functionality and Microbiome Activity

  2025influential citation
• A critical review of microbiome-derived metabolic functions and translational research in liver diseases

  2025cites this paper
• Metabolomics Network Analysis of Various Genotypes Associated with Schizophrenia Gene Variant

  2025influential citation
• FECAL CALPROTECTIN AND INTESTINAL METABOLITES: WHAT IS THEIR IMPORTANCE IN THE ACTIVITY AND DIFFERENTIATION OF PATIENTS WITH INFLAMMATORY BOWEL DISEASES?

  2025cites this paper
• Identification of Biomarkers for Treatment Escalation of Ulcerative Colitis Based on Untargeted Metabolomics and Machine Learning Algorithms: A Prospective Cohort Study

  2025cites this paper
• Microbes with higher metabolic independence are enriched in human gut microbiomes under stress

  2025cites this paper
• Therapeutic potential of Xihuang Pill in colorectal cancer: Metabolomic and microbiome-driven approaches

  2024cites this paper
• Serotonin Transporter Deficiency Induces Metabolic Alterations in the Ileal Mucosa

  2024cites this paper
• Probiotic Bacillus cereus regulates metabolic disorders and activates the cholic acid-FXR axis to alleviate DSS-induced colitis.

  2024cites this paper
• Integrated Analysis of Microbiome and Metabolome Reveals Disease-Specific Profiles in Inflammatory Bowel Diseases and Intestinal Behçet’s Disease

  2024cites this paper
• Fecal microbiota and concentrations of long-chain fatty acids, sterols, and unconjugated bile acids in cats with chronic enteropathy

  2024influential citation
• Faecal volatile organic compounds differ according to inflammatory bowel disease sub‐type, severity, and response to treatment in paediatric patients

  2024influential citation
• Multi-omics analysis of the gut microbiome and metabolites associated with the psychoneurological symptom cluster in children with cancer receiving chemotherapy

  2024cites this paper
• Trace Amine-Associated Receptors’ Role in Immune System Functions

  2024cites this paper
• Metabolomics for enhanced clinical understanding of inflammatory bowel disease.

  2024cites this paper
• Explainable AI-prioritized plasma and fecal metabolites in inflammatory bowel disease and their dietary associations

  2024cites this paper
• Untargeted faecal metabolomics for the discovery of biomarkers and treatment targets for inflammatory bowel diseases

  2024influential citation
• Metabolomic insights into the beneficial effects of dietary purple potato on DSS-induced murine colon colitis

  2024cites this paper
• Predicting Outcomes of Preterm Neonates Post Intraventricular Hemorrhage

  2024cites this paper
• Surgery for Crohn’s Disease Is Associated With a Dysbiotic Microbiome and Metabolome: Results From Two Prospective Cohorts

  2024cites this paper
• Unbiased serum metabolomic analysis in cats with naturally occurring chronic enteropathies before and after medical intervention

  2024cites this paper
• Leveraging Organ‐on‐Chip Models to Investigate Host–Microbiota Dynamics and Targeted Therapies for Inflammatory Bowel Disease

  2024cites this paper
• Serum metabolomics signature of maternally inherited diabetes and deafness by gas chromatography–time of flight mass spectrometry

  2024influential citation
• Host–pathobiont interactions in Crohn’s disease

  2024cites this paper
• Big Data in Gastroenterology Research

  2023cites this paper
• The gut microbiota and metabolome are associated with diminished COVID-19 vaccine-induced antibody responses in immunosuppressed inflammatory bowel disease patients

  2023cites this paper
• Effects of pork sausage on intestinal microecology and metabolism in mice.

  2023cites this paper
• Application of Benchtop NMR for Metabolomics Study Using Feces of Mice with DSS-Induced Colitis

  2023cites this paper
• Aged oolong tea alleviates dextran sulfate sodium-induced colitis in mice by modulating the gut microbiota and its metabolites

  2023cites this paper
• Gut Health and Influencing Factors in Pigs

  2023cites this paper
• Multi-omics in Crohn's disease: New insights from inside

  2023cites this paper
• Faecal metabolome and its determinants in inflammatory bowel disease

  2023cites this paper
• Fecal Microbial Structure and Metabolic Profile in Post-Weaning Diarrheic Piglets

  2023cites this paper
• Mucosal Metabolomic Signatures in Chronic Colitis: Novel Insights into the Pathophysiology of Inflammatory Bowel Disease

  2023cites this paper
• Gut microbiota analyses of inflammatory bowel diseases from a representative Saudi population

  2023influential citation
• Application of untargeted volatile profiling in inflammatory bowel disease research

  2023cites this paper
• Are We Ready to Reclassify Crohn’s Disease Using Molecular Classification?

  2023cites this paper
• Dietary (poly)phenols mitigate inflammatory bowel disease: Therapeutic targets, mechanisms of action, and clinical observations

  2023cites this paper
• The effects of ambient temperature exposure on feline fecal metabolome

  2023cites this paper
• Comparative analysis of the synergetic effects of Diwuyanggan prescription on high fat diet-induced non-alcoholic fatty liver disease using untargeted metabolomics

  2023influential citation
• Microbes with higher metabolic independence are enriched in human gut microbiomes under stress

  2023cites this paper
• Unique beta-glucuronidase locus in gut microbiomes of crohn’s disease patients and unaffected first-degree relatives

  2023cites this paper
• Gut microbiota in pathophysiology, diagnosis, and therapeutics of inflammatory bowel disease

  2023cites this paper
• Advances in gut microbiome in metabonomics perspective: based on bibliometrics methods and visualization analysis

  2023cites this paper
• Bile acids as inflammatory mediators and modulators of intestinal permeability

  2022influential citation
• Discovery and Validation of Potential Serum Biomarkers with Pro-Inflammatory and DNA Damage Activities in Ulcerative Colitis: A Comprehensive Untargeted Metabolomic Study

  2022cites this paper
• Comprehensive Phenotyping in Inflammatory Bowel Disease: Search for Biomarker Algorithms in the Transkingdom Interactions Context

  2022cites this paper
• Identification of Glucocorticoid Receptor Antagonistic Activities and Responsible Compounds in House Dust: Bioaccessibility Should Not Be Ignored.

  2022cites this paper
• Chemometrics assisted untargeted metabolomic analysis to explore metabolic alterations in chronic urticaria via LC/Q-TOF/MS/MS

  2022cites this paper
• Using Untargeted LC-MS Metabolomics to Identify the Association of Biomarkers in Cattle Feces with Marbling Standard Longissimus Lumborum

  2022cites this paper
• A rapid and standardized workflow for functional assessment of bacterial biosensors in fecal samples

  2022influential citation
• The gut microbiome molecular complex in human health and disease.

  2022cites this paper
• Metabolic analyses reveal dysregulated NAD+ metabolism and altered mitochondrial state in ulcerative colitis

  2022cites this paper
• Colonocyte-derived lactate promotes E. coli fitness in the context of inflammation-associated gut microbiota dysbiosis

  2022cites this paper
• Metaomics in Clinical Laboratory: Potential Driving Force for Innovative Disease Diagnosis

  2022cites this paper
• Faecal Metabolomics in Paediatric Inflammatory Bowel Disease: A Systematic Review

  2022cites this paper
• In Silico Structure Predictions for Non-targeted Analysis: From Physicochemical Properties to Molecular Structures.

  2022cites this paper
• Intestinal microbiome and modern methods of its study in children

  2022cites this paper
• Effects of perinatal TCDD exposure on colonic microbiota and metabolism in offspring and mother mice.

  2022cites this paper
• Metabolomics Applied to Cord Serum in Preeclampsia Newborns: Implications for Neonatal Outcomes

  2022cites this paper
• Inflammatory Bowel Disease and COVID-19: How Microbiomics and Metabolomics Depict Two Sides of the Same Coin

  2022cites this paper
• Gut microbiota-derived bile acids in intestinal immunity, inflammation, and tumorigenesis.

  2022cites this paper
• Effects of bowel preparation on intestinal bacterial associated urine and faecal metabolites and the associated faecal microbiome

  2022cites this paper
• Effect of chronic and acute enterotoxigenic E. coli challenge on growth performance, intestinal inflammation, microbiome, and metabolome of weaned piglets

  2022cites this paper
• Microbial dysbiosis and fecal metabolomic perturbations in Yorkshire Terriers with chronic enteropathy

  2022cites this paper
• Microbiome risk profiles as biomarkers for inflammatory and metabolic disorders

  2022cites this paper
• Synthesis and identification of lithocholic acid 3‐sulfate as RORγt ligand to inhibit Th17 cell differentiation

  2022cites this paper
• Exploration of the Potential Relationship Between Gut Microbiota Remodeling Under the Influence of High-Protein Diet and Crohn’s Disease

  2022cites this paper
• Diallyl Disulfide (DADS) Ameliorates Intestinal Candida albicans Infection by Modulating the Gut microbiota and Metabolites and Providing Intestinal Protection in Mice

  2022cites this paper
• Computational approach to modeling microbiome landscapes associated with chronic human disease progression

  2022cites this paper
• Rapid prototyping of metabolites detection by bacterial biosensors in human fecal samples

  2022cites this paper
• Bile Acids: Key Players in Inflammatory Bowel Diseases?

  2022cites this paper
• Role of dietary amino acids and microbial metabolites in the regulation of pig intestinal health

  2021cites this paper
• Fecal Amino Acid Analysis in Newly Diagnosed Pediatric Inflammatory Bowel Disease: A Multicenter Case-Control Study

  2021cites this paper
• Microbiome-Mediated Immune Signaling in Inflammatory Bowel Disease and Colorectal Cancer: Support From Meta-omics Data

  2021cites this paper
• Metabolomics activity screening of T cell–induced colitis reveals anti-inflammatory metabolites

  2021cites this paper
• Osmolality-based normalization enhances statistical discrimination of untargeted metabolomic urine analysis: results from a comparative study

  2021cites this paper
• The assessment of plasma fatty acid profiles in newly diagnosed treatment-naive paediatric Crohn's disease.

  2021cites this paper
• Systematic Review of Recent Lipidomics Approaches Toward Inflammatory Bowel Disease

  2021cites this paper
• Gut Microbiome and Gastrointestinal Disorders

  2021cites this paper
• Development and Characterization of a Weaned Pig Model of Shiga Toxin–Producing E. coli-Induced Gastrointestinal Disease

  2021cites this paper
• Metabolomics Insights into Inflammatory Bowel Disease: A Comprehensive Review

  2021cites this paper
• Alterations in the Fecal Microbiome and Metabolome of Horses with Antimicrobial-Associated Diarrhea Compared to Antibiotic-Treated and Non-Treated Healthy Case Controls

  2021cites this paper
• Optimization of Sample Preparation for Metabolomics Exploration of Urine, Feces, Blood and Saliva in Humans Using Combined NMR and UHPLC-HRMS Platforms

  2021cites this paper
• Closing the gap between in vivo and in vitro omics: using QA/QC to strengthen ex vivo NMR metabolomics

  2021cites this paper
• Detection of the Inflammatory Bowel Diseases via Machine Learning Methods

  2021cites this paper
• The role of fecal sulfur metabolome in inflammatory bowel diseases.

  2021cites this paper
• Targeted 1H NMR metabolomics and immunological phenotyping of human fresh blood and serum samples discriminate between healthy individuals and inflammatory bowel disease patients treated with anti-TNF

  2021cites this paper
• Untargeted Metabolomics Reveals Intestinal Pathogenesis and Self-Repair in Rabbits Fed an Antibiotic-Free Diet

  2021cites this paper